5-HT3 길항제

• 5-HT3 receptors.Current pharmaceutical design · 2006
• Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends.Cancer treatment and research communications · 2021
• Combination of 5-HT3 Antagonist and Dexamethasone Is Superior to 5-HT3 Antagonist Alone for PONV Prophylaxis After Laparoscopic Surgeries: A Meta-analysis.Anesthesia and analgesia · 2016
• Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials.ESMO open · 2020
• Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat.Behavioural pharmacology · 2021

via PubMed

Wikidata facts